Gritstone Oncology Inc sell Lokrim
Start price
02.04.24
/
20%
€1.28
Target price
02.04.25
-
Performance (%)
-30.08%
Price
03.05.24
€0.89
Summary
This prediction is currently active. The SELL prediction by Lokrim for Gritstone Oncology Inc is performing very well with a performance of -30.08%. This prediction currently runs until 02.04.25. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Gritstone Oncology Inc | 16.156% | 16.156% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
According to Lokrim what are the pros and cons of Gritstone Oncology Inc for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Below average Marketposition
Higher risks for its business
Comments by Lokrim for this prediction
In the thread Gritstone Oncology Inc diskutieren
Sell Gritstone Oncology Inc
Stopped prediction by Lokrim for Gritstone Oncology Inc
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€5.92
09.08.21
09.08.21
-
09.08.22
09.08.22
-41.72%
10.08.22
10.08.22
Probably not worthwhile Investment
Below average Marketposition
